The central Indiana area has been selected as one of 15 communities that will share in $220 million worth of grants for pilot
projects to test health-care information technology.
The two largest U.S. health insurance companies, UnitedHealth, based in Minnetonka, Minn., and WellPoint Inc., based in Indianapolis,
sell Advantage plans.
Huntington National Bank, a subsidiary of Huntington Bancshares, operates nearly 50 branches and has about 600 employees in
the Indianapolis area.
Once-weekly form of Byetta is awaiting the FDA’s OK. Analyst predict the new version of the drug, if approved, could rack
up sales of $2 billion annually.
Eli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.’s plan to
combine their veterinary units.
Carmel-based insurer Conseco Inc. will ask shareholders to approve changing the company’s name to CNO Financial Group,
the company said Thursday morning.
BMW has won a contract from Indiana-based Carbon Motors Corp. worth more than $1.35 billion to supply engines for U.S. police
cars.
Drugmakers and insurers could gain millions of customers under the legislation, but the industry also will pay new fees and
face stricter rules that may shrink profit and fuel mergers.
Indianapolis-based health insurer expects revenue, profit to fall as persistently high unemployment reduces employer-sponsored
insurance enrollment.
Annual unscientific survey does not take into account that many employees who participate in office pools devote extra time
to finishing their responsibilities.
WellPoint Inc.’s Anthem Blue Cross & Blue Shield of Connecticut may constrain competition through contracts that require
that the insurer receives hospital discounts at least as favorable as any provided to a competitor.
Republic has agreed to buy 40 Bombardier Inc. CS300 regional jets valued at $3.06 billion, the largest order for the aircraft
since its introduction in 2008.
The pharmacy benefits manager, which has major operations in Whitestown, said fourth quarter profit rose 24 percent.
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators’
clearance of a similar drug.
